# PDO Based Drug Sensitive Test in R/M SGC

> **NCT06686979** · — · RECRUITING · sponsor: **Huashan Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Salivary Gland Cancers
- Patient Derived Organoid
- Drug Sensitive Test in Vitro

## Interventions

- **OTHER:** No Intervention: Observational Cohort

## Key facts

- **NCT ID:** NCT06686979
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-26
- **Primary completion:** 2026-11-30
- **Final completion:** 2028-11-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-09-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06686979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06686979, "PDO Based Drug Sensitive Test in R/M SGC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06686979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*